Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

A New Trend of Digital Healthcare in 3D Printed Medicines

View through CrossRef
Three-dimensional ‎(‎3D) technique of restricting scrambling is changing the ways of drug design, labeling and ‎production in the area of ‎digital health. By combining digital and genetic techniques, Fused ‎Deposition Modeling (FDM) can manufacture ‎normalization systems. Consecutively, such a ‎method can allow for speedy improvements in the healthcare ‎systems, allowing the allocation ‎of medicines based on patient’s needs and requirements. So far, several 3D ‎based medicinal ‎goods have been marketed. These include the production of implants and several useful related ‎‎products for use in medical applications. Nevertheless, regulatory obstacles remain with ‎developing medicines. ‎This article reviews the latest FDM technology in medical and ‎pharmaceutical research, including a discussion of ‎the potential challenges in the field. ‎Emphasis has been paid on future developments needed for facilitating the ‎FDM integration ‎into dispensaries and clinics.‎
Title: A New Trend of Digital Healthcare in 3D Printed Medicines
Description:
Three-dimensional ‎(‎3D) technique of restricting scrambling is changing the ways of drug design, labeling and ‎production in the area of ‎digital health.
By combining digital and genetic techniques, Fused ‎Deposition Modeling (FDM) can manufacture ‎normalization systems.
Consecutively, such a ‎method can allow for speedy improvements in the healthcare ‎systems, allowing the allocation ‎of medicines based on patient’s needs and requirements.
So far, several 3D ‎based medicinal ‎goods have been marketed.
These include the production of implants and several useful related ‎‎products for use in medical applications.
Nevertheless, regulatory obstacles remain with ‎developing medicines.
‎This article reviews the latest FDM technology in medical and ‎pharmaceutical research, including a discussion of ‎the potential challenges in the field.
‎Emphasis has been paid on future developments needed for facilitating the ‎FDM integration ‎into dispensaries and clinics.
‎.

Related Results

Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Abstract Introduction Telemedicine is the remote delivery of healthcare services using information and communication technologies and has gained global recognition as a solution to...
A Case Study of the Registration of Essential Medicines in the East African Community
A Case Study of the Registration of Essential Medicines in the East African Community
Abstract Objective: To quantify the essential medicine status of registered medicines in the East African Community (EAC) for antimicrobial medicines and medicines for non-...
Interoperability in Digital Healthcare: Enhancing Consumer Health and Transforming Care Systems
Interoperability in Digital Healthcare: Enhancing Consumer Health and Transforming Care Systems
Background: Interoperability is a central pillar of digital healthcare transformation that enables the smooth transfer of healthcare information, care coordination, and the perform...
E-Press and Oppress
E-Press and Oppress
From elephants to ABBA fans, silicon to hormone, the following discussion uses a new research method to look at printed text, motion pictures and a te...
Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers
Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers
Objective To explore the perceptions of Australian consumers and carers about the financial burden associated with medicines used for the treatment of chronic conditions. Method Se...
The availability of medicines in Spain
The availability of medicines in Spain
In the European Union (EU) procedures for the authorization of medicinal products are applied to incorporate new medicinal products and their successive amendments under the same c...

Back to Top